PAXVAX, INC.
Redwood City, US
Biotech
Founders & leadership
JC
James ConnollyNamed on SEC filing
HB
Howard B. RosenNamed on SEC filing
RT
Richard TongNamed on SEC filing
HG
Henry G. Coit, Jr.Named on SEC filing
KJ
Kenneth J. KelleyNamed on SEC filing
PR
Phil RussellNamed on SEC filing
Reported raises · per SEC filings
Form D private placements$40.9M disclosed across 2 rounds · 2013–2014
▶$34.9MraisedAug 2014 · 9 investors · PharmaceuticalsRule 506(b)
▶$34.9MraisedAug 2014 · 9 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- HENRY G. COIT, JR.Director
- JAMES CONNOLLYDirector
- RICHARD TONGDirector
- KENNETH J. KELLEYExecutive Officer, Director
- PHIL RUSSELLDirector
- HOWARD B. ROSENDirector
- Offering amount
- $35.5M
- Amount sold
- $34.9M
- First sale
- Dec 2013
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$6MraisedApr 2014 · 2 investors · PharmaceuticalsRule 506(b)
▶$6MraisedApr 2014 · 2 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- James ConnollyDirector
- Howard B. RosenDirector
- Richard TongDirector
- Henry G. Coit, Jr.Director
- Kenneth J. KelleyExecutive Officer, Director
- Phil RussellDirector
- Offering amount
- $15M
- Amount sold
- $6M
- First sale
- Apr 2014
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Non-dilutive funding · 7 SBIR/STTR awards
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2015 | $1.8M |
| Department of DefenseDefense Health Program | Phase II | 2015 | $1M |
| U.S. ArmyArmy | Phase I | 2014 | $1.4M |
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2012 | $3M |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2012 | $548.8K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2012 | $298.5K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2010 | $300K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
Frequently asked questions
- How much funding has PAXVAX, INC. raised?
- PAXVAX, INC. has disclosed $40.9M raised across 2 rounds.
- Where is PAXVAX, INC. headquartered?
- PAXVAX, INC. is headquartered in Redwood City, US.